Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carla Rodriguez-Mogeda

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Angiogenesis|April 29, 2023
Correction: Nectins and Nectin-like molecules drive vascular development and barrier functionDoryssa Hermans, Carla Rodriguez-Mogeda, Hannelore Kemps, et al.
Angiogenesis|March 3, 2023
Nectins and Nectin-like molecules drive vascular development and barrier functionDoryssa Hermans, Carla Rodriguez-Mogeda, Hannelore Kemps, et al.
Biomolecules|June 24, 2022
Breaching Brain Barriers: B Cell Migration in Multiple SclerosisCarla Rodriguez-Mogeda, Sabela Rodríguez-Lorenzo, Jiji Attia, et al.
Journal of Neuroinflammation|February 13, 2024
The role of CD56<sup>bright</sup> NK cells in neurodegenerative disordersCarla Rodriguez-Mogeda, Chaja M J van Ansenwoude, Lennart van der Molen, et al.
Elife|May 10, 2022
Single-cell profiling reveals periventricular CD56<sup>bright</sup> NK cell accumulation in multiple sclerosisSabela Rodríguez-Lorenzo, Lynn van Olst, Carla Rodriguez-Mogeda, et al.
Frontiers in Immunology|March 14, 2025
The gut-brain-axis one year after treatment with cladribine tablets in patients with relapsing remitting multiple sclerosis: a pilot studyJeske van Pamelen, Carla Rodriguez-Mogeda, Lynn van Olst, et al.
Scientific Reports|October 27, 2024
Intrathecal IgG and IgM synthesis correlates with neurodegeneration markers and corresponds to meningeal B cell presence in MSCarla Rodriguez-Mogeda, Melissa Mj van Gool, Richard van der Mast, et al.
Journal of Neuroinflammation|September 26, 2023
Extended interval dosing of ocrelizumab modifies the repopulation of B cells without altering the clinical efficacy in multiple sclerosisCarla Rodriguez-Mogeda, Zoë Y G J van Lierop, Susanne M A van der Pol, et al.
Acta Neuropathologica|May 28, 2025
Thalamic atrophy in multiple sclerosis is associated with tract disconnection and altered microgliaCarla Rodriguez-Mogeda, Ismail Koubiyr, Stefanos E Prouskas, et al.
Acta Neuropathologica|March 29, 2021
Meningeal inflammation in multiple sclerosis induces phenotypic changes in cortical microglia that differentially associate with neurodegenerationLynn van Olst, Carla Rodriguez-Mogeda, Carmen Picon, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Angiogenesis|April 29, 2023
Correction: Nectins and Nectin-like molecules drive vascular development and barrier functionDoryssa Hermans, Carla Rodriguez-Mogeda, Hannelore Kemps, et al.
Angiogenesis|March 3, 2023
Nectins and Nectin-like molecules drive vascular development and barrier functionDoryssa Hermans, Carla Rodriguez-Mogeda, Hannelore Kemps, et al.
Biomolecules|June 24, 2022
Breaching Brain Barriers: B Cell Migration in Multiple SclerosisCarla Rodriguez-Mogeda, Sabela Rodríguez-Lorenzo, Jiji Attia, et al.
Journal of Neuroinflammation|February 13, 2024
The role of CD56<sup>bright</sup> NK cells in neurodegenerative disordersCarla Rodriguez-Mogeda, Chaja M J van Ansenwoude, Lennart van der Molen, et al.
Elife|May 10, 2022
Single-cell profiling reveals periventricular CD56<sup>bright</sup> NK cell accumulation in multiple sclerosisSabela Rodríguez-Lorenzo, Lynn van Olst, Carla Rodriguez-Mogeda, et al.
Frontiers in Immunology|March 14, 2025
The gut-brain-axis one year after treatment with cladribine tablets in patients with relapsing remitting multiple sclerosis: a pilot studyJeske van Pamelen, Carla Rodriguez-Mogeda, Lynn van Olst, et al.
Scientific Reports|October 27, 2024
Intrathecal IgG and IgM synthesis correlates with neurodegeneration markers and corresponds to meningeal B cell presence in MSCarla Rodriguez-Mogeda, Melissa Mj van Gool, Richard van der Mast, et al.
Journal of Neuroinflammation|September 26, 2023
Extended interval dosing of ocrelizumab modifies the repopulation of B cells without altering the clinical efficacy in multiple sclerosisCarla Rodriguez-Mogeda, Zoë Y G J van Lierop, Susanne M A van der Pol, et al.
Acta Neuropathologica|May 28, 2025
Thalamic atrophy in multiple sclerosis is associated with tract disconnection and altered microgliaCarla Rodriguez-Mogeda, Ismail Koubiyr, Stefanos E Prouskas, et al.
Acta Neuropathologica|March 29, 2021
Meningeal inflammation in multiple sclerosis induces phenotypic changes in cortical microglia that differentially associate with neurodegenerationLynn van Olst, Carla Rodriguez-Mogeda, Carmen Picon, et al.
Pageof 2